Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice
暂无分享,去创建一个
I. Shimomura | S. Fukuda | Y. Obata | H. Nishizawa | N. Maeda | S. Kita | S. Miyagawa | Y. Sawa | Y. Takakura | Yuki Takahashi | Y. Fujishima | Yuto Nakamura | Yusuke Kawachi | Y. Tanaka | Tomonori Okita | Yuri Tsugawa-Shimizu | H. Nishida | Yoshimitsu Tanaka | Hiroyuki Nishida | Shunbun Kita | Yoshinari Obata
[1] M. Pittenger,et al. Mesenchymal stem cell perspective: cell biology to clinical progress , 2019, npj Regenerative Medicine.
[2] A. James,et al. PDGFRα marks distinct perivascular populations with different osteogenic potential within adipose tissue , 2019, Stem cells.
[3] I. Shimomura,et al. Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin , 2019, eLife.
[4] I. Shimomura,et al. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. , 2019, The Journal of clinical investigation.
[5] N. Asai,et al. Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin in Cardiac Tissue Repair and the Development of Diastolic Dysfunction. , 2019, Circulation research.
[6] Junnan Tang,et al. microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. , 2019, The Journal of clinical investigation.
[7] J. T. Afshari,et al. Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease. , 2019, Atherosclerosis.
[8] I. Shimomura,et al. Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype , 2019, Cardiovascular Diabetology.
[9] P. Scherer,et al. Metabolic Messengers: adiponectin , 2019, Nature Metabolism.
[10] T. Funahashi,et al. Adiponectin promotes muscle regeneration through binding to T-cadherin , 2019, Scientific Reports.
[11] Yolan J. Reckman,et al. Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] Kazuya Kobayashi,et al. Mesenchymal Stem/Stromal Cell-Based Therapy for Heart Failure - What Is the Best Source? , 2018, Circulation journal : official journal of the Japanese Circulation Society.
[13] S. Miyagawa,et al. Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[14] K. Hatzistergos,et al. Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] A. Amin,et al. Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats , 2018, Scientific Reports.
[16] E. Fukusaki,et al. Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. , 2018, JCI insight.
[17] C. Muramatsu,et al. S1P–S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction , 2018, Circulation research.
[18] J. Duffield,et al. Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies , 2018, Science Translational Medicine.
[19] M. Pittenger,et al. Concise Review: MSC‐Derived Exosomes for Cell‐Free Therapy , 2017, Stem cells.
[20] T. Funahashi,et al. The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2 , 2017, The Journal of Biological Chemistry.
[21] T. Funahashi,et al. Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] M. Mattson,et al. Impact of lysosome status on extracellular vesicle content and release , 2016, Ageing Research Reviews.
[23] Clotilde Théry,et al. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.
[24] N. Asai,et al. Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells , 2016, Scientific Reports.
[25] J. Kastrup,et al. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). , 2015, European heart journal.
[26] A. Williamson,et al. Comparative Quantification of the Surfaceome of Human Multipotent Mesenchymal Progenitor Cells , 2015, Stem cell reports.
[27] Yuki Takahashi,et al. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice , 2015, Journal of extracellular vesicles.
[28] C. Théry,et al. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.
[29] O. Korsgren,et al. Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells , 2014, Diabetes.
[30] N. Khandelwal,et al. Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study , 2014, Cell transplantation.
[31] P. Robbins,et al. Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.
[32] Ryosuke Kikuchi,et al. T-cadherin Is Essential for Adiponectin-mediated Revascularization* , 2013, The Journal of Biological Chemistry.
[33] Yuki Takahashi,et al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. , 2013, Journal of biotechnology.
[34] Thomas Würdinger,et al. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. , 2013, Blood.
[35] Changjin Lee,et al. Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension , 2012, Circulation.
[36] D. Grieve,et al. Surgical optimization and characterization of a minimally invasive aortic banding procedure to induce cardiac hypertrophy in mice , 2012, Experimental physiology.
[37] Lanjuan Li,et al. In vivo hepatic differentiation of mesenchymal stem cells from human umbilical cord blood after transplantation into mice with liver injury. , 2012, Biochemical and biophysical research communications.
[38] Ylva Ivarsson,et al. Syndecan–syntenin–ALIX regulates the biogenesis of exosomes , 2012, Nature Cell Biology.
[39] Jeffrey M Karp,et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. , 2012, Cell stem cell.
[40] H. Hirose,et al. Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. , 2010, Journal of atherosclerosis and thrombosis.
[41] P. Ruiz-Lozano,et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.
[42] Gerard Pasterkamp,et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.
[43] J. Karp,et al. Mesenchymal stem cell therapy: Two steps forward, one step back. , 2010, Trends in Molecular Medicine.
[44] Alessandro Giacomello,et al. Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice , 2010, Circulation research.
[45] K. Tsuchida,et al. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle , 2010, Nature Cell Biology.
[46] S. Kihara,et al. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. , 2009, Cardiovascular research.
[47] T. Ochiya,et al. IFATS Collection: In Vivo Therapeutic Potential of Human Adipose Tissue Mesenchymal Stem Cells After Transplantation into Mice with Liver Injury , 2008, Stem cells.
[48] I. B. Borel Rinkes,et al. Mesenchymal Stem Cell Therapy for Protection and Repair of Injured Vital Organs , 2008 .
[49] Toshihiko Uchida,et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. , 2007, The American journal of cardiology.
[50] R. Rizza,et al. Selective Downregulation of the High–Molecular Weight Form of Adiponectin in Hyperinsulinemia and in Type 2 Diabetes , 2007, Diabetes.
[51] R. Robbins,et al. Stem cell transplantation: the lung barrier. , 2007, Transplantation proceedings.
[52] S. Kihara,et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.
[53] Armand Keating,et al. Mesenchymal stromal cells , 2006, Stem Cell Biology and Regenerative Medicine.
[54] J. Couzin. The Ins and Outs of Exosomes , 2005, Science.
[55] H. Lodish,et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[56] Shinji Kihara,et al. Importance of Adipocytokines in Obesity-Related Diseases , 2003, Hormone Research in Paediatrics.
[57] M. Cnop,et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.
[58] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[59] Younan Chen,et al. Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[60] M. Murad,et al. Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. , 2016, The Lancet. Haematology.